2022 - Research.com Best Female Scientist Award
The scientist’s investigation covers issues in Internal medicine, Breast cancer, Carcinogen, Molecular biology and Odds ratio. Her studies in Internal medicine integrate themes in fields like Endocrinology, Oncology, Gastroenterology, Genotype and Vitamin E. Her Breast cancer study is focused on Cancer in general.
Regina M. Santella combines subjects such as Fetus, Adduct and DNA, DNA damage with her study of Carcinogen. Her work carried out in the field of DNA brings together such families of science as DNA methylation and Benzopyrene. Her Odds ratio research is multidisciplinary, relying on both Immunology, Case-control study, Confidence interval and Risk factor.
Her primary scientific interests are in Internal medicine, Breast cancer, Oncology, Cancer and Molecular biology. Her biological study spans a wide range of topics, including Gastroenterology and Endocrinology. Her Breast cancer study combines topics from a wide range of disciplines, such as DNA methylation and Single-nucleotide polymorphism, Genotype.
The study incorporates disciplines such as Epidemiology, Prostate Cancer Prevention Trial, Gynecology, Proportional hazards model and Prostate cancer in addition to Oncology. Her Cancer research incorporates themes from Cancer research, Methylation, Family history and Pathology. As a part of the same scientific study, Regina M. Santella usually deals with the Molecular biology, concentrating on DNA and frequently concerns with Adduct, Carcinogen, Pyrene and Stereochemistry.
Her primary areas of study are Internal medicine, Breast cancer, Oncology, DNA methylation and Odds ratio. Her study focuses on the intersection of Breast cancer and fields such as Genome-wide association study with connections in the field of Genetic predisposition. Her Oncology research incorporates elements of Prostate Cancer Prevention Trial, Area under the curve, Gynecology and Family history.
Her study in DNA methylation is interdisciplinary in nature, drawing from both Molecular biology, Methylation and Epigenetics. Her research investigates the connection between Methylation and topics such as Immunology that intersect with problems in Peripheral blood mononuclear cell. Her study on Odds ratio also encompasses disciplines like
Internal medicine, Breast cancer, Oncology, DNA methylation and Odds ratio are her primary areas of study. Her Internal medicine research integrates issues from Gastroenterology and Endocrinology. Breast cancer is the subject of her research, which falls under Genetics.
Her research integrates issues of Area under the curve, Retrospective cohort study, Deep sequencing and Nucleotide excision repair, DNA repair in her study of Oncology. Regina M. Santella has included themes like Methylation, DNA, Carcinogenesis, Immunology and Molecular biology in her DNA methylation study. She has researched Odds ratio in several fields, including Body mass index, Tobacco smoke, Toxicology and Environmental exposure.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Scott M. Lippman;Eric A. Klein;Eric A. Klein;Phyllis J. Goodman;M. Scott Lucia.
Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies
N. Hamajima;K. Hirose;K. Tajima;T. Rohan.
Lancet Oncology (2012)
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
Kyriaki Michailidou;Jonathan Beesley;Sara Lindstrom;Sander Canisius.
Nature Genetics (2015)
Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.
Wei Jiang;S. M. Kahn;Ping Zhou;Yu-Jing Zhang.
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.
Wei Jiang;Yu-Jing Zhang;S. M. Kahn;M. C. Hollstein.
Proceedings of the National Academy of Sciences of the United States of America (1993)
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Scott M. Lippman;Phyllis J. Goodman;Eric A. Klein;Howard L. Parnes.
Journal of the National Cancer Institute (2005)
Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood
Fang Fang Zhang;Roberto Cardarelli;Joan Carroll;Kimberly G. Fulda.
Detection of smoking-related covalent DNA adducts in human placenta
Richard B. Everson;Erika Randerath;Regina M. Santella;Robert C. Cefalo.
Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence
N. Hamajima;K. Hirose;K. Tajima;T. Rohan.
The Lancet (2019)
DNA methylation in white blood cells: Association with risk factors in epidemiologic studies
Mary Beth Terry;Lissette Delgado-Cruzata;Neomi Vin-Raviv;Hui Chen Wu.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: